Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. (Q47904576)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2002

Language	Label	Description	Also known as
English	Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.	scientific article published in May 2002

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Plasmodium falciparum

0 references

0 references

Plasmodium falciparum malaria

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

Arnoldo Barbosa

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Manuel-Elkin Patarroyo

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

9

object named as

Gerd Pluschke

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

Oscar Kashala

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Roberto Amador

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Maria V Valero

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Beatrice Nickel

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Claudia A Daubenberger

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Fanny Guzman

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

17-18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

2263-2277

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Malaria vaccine development: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of protective immunity against experimental infection with malaria using synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of SPf66 malaria vaccine efficacy in Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The SPf66 Malaria Vaccine: What is the Evidence for Efficacy?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

QS-21: a water-soluble triterpene glycoside adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of adjuvants and delivery systems in modulation of immune response to vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Major adverse reactions to yeast-derived hepatitis B vaccines--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccines against the blood stages of falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell control of immunity to the asexual blood stages of the malaria parasite.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900115-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(02)00115-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12009282%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47904576&oldid=1726614467"